# Nevirapine / Lamivudine for HIV Maintenance Therapy

> **NCT07014189** · PHASE4 · COMPLETED · sponsor: **Cantonal Hospital of St. Gallen** · enrollment: 201 (actual)

## Conditions studied

- HIV Infection
- Antiretroviral Treatment
- Maintenance Therapy

## Interventions

- **DRUG:** Neviparine (NVP)/ Lamivudine (3TC)

## Key facts

- **NCT ID:** NCT07014189
- **Lead sponsor:** Cantonal Hospital of St. Gallen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-12
- **Primary completion:** 2023-01-10
- **Final completion:** 2023-08-31
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2025-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07014189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07014189, "Nevirapine / Lamivudine for HIV Maintenance Therapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07014189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*